Regulatory PathRegulatory requirements compared

Active substances

Hydrochlorothiazide + Olmesartan

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CO-OLMEPRESS 20 mg/12.5 mg F.C. Tablet20,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 48.80Generic · PrescriptionLABORATORIOS CINFA SAValid
CO-OLMEPRESS 40 mg/12.5 mg F.C. Tablet40,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 66.15Generic · PrescriptionLABORATORIOS CINFA SAValid
CO-OLMEPRESS 40 mg/25 mg F.C. Tablet40,25 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 66.15Generic · PrescriptionLABORATORIOS CINFA SAValid
Erastapecs Plus 20/12.5MG F.C.TABLET20,12.5 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 47.95Generic · PrescriptionApex PharmaValid
Erastapecs Plus 40/12.5MG F.C.TABLET40,12.5 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 63.80Generic · PrescriptionApex PharmaValid
NORMATEC PLUS 20/12.5 mg film-coated tablet20,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 59.20Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
NORMATEC PLUS 40/12.5 mg film-coated tablet40,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 78.80Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
NORMATEC PLUS 40/25 mg film-coated tablet40,25 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 78.80Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
OLMAZIDE 20/12.5MG F.C.TABLET20,12.5 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 47.95Generic · PrescriptionSaudi AmaroxValid
OLMAZIDE 40/12.5MG40,12.5 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 63.80Generic · PrescriptionSaudi AmaroxValid
OLMAZIDE 40/25MG40,25 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 63.80Generic · PrescriptionSaudi AmaroxValid
OLMETEC PLUS 20MG-12.5MG F.C. TABLETS20,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 65.60NCE · PrescriptionSAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL COValid
OLMETEC PLUS 40MG-12.5MG F.C. TABLETS40,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 87.30NCE · PrescriptionSAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL COValid
OLMETEC PLUS 40MG-25MG F.C. TABLETS40,25 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 87.30NCE · PrescriptionSAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL COValid
Olcontro HCT20,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 33.55Generic · PrescriptionMed City PharmaValid
Olcontro HCT40,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 44.65Generic · PrescriptionMed City PharmaValid
Olmetrol Plus40,12.5 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 63.80Generic · PrescriptionRIYADH PHARMAValid
Olmetrol Plus20,12.50 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 47.95Generic · PrescriptionRIYADH PHARMAValid
Olmetrol Plus40,25 mg,mgFilm-coated tablet · Oral use30 BlisterSAR 63.80Generic · PrescriptionRIYADH PHARMAValid
Olsar Plus40,25 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 70.90Generic · PrescriptionJamjoom Pharmaceuticals Factory CompanyValid
Olsar Plus40,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 70.90Generic · PrescriptionJamjoom Pharmaceuticals Factory CompanyValid
Olsar Plus20,12.5 mg,mgFilm-coated tablet · Oral use28 BlisterSAR 53.30Generic · PrescriptionJamjoom Pharmaceuticals Factory CompanyValid
Indications — CHI Daman Drug Formulary

HYPERTENSION

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
BENICAR HCT12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralCOSETTEPrescription5 Jun 2003
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralALEMBICPrescription24 Apr 2017
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralAUROBINDO PHARMAPrescription24 Apr 2017
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralPRINSTON INCPrescription24 Apr 2017
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralACCORD HLTHCAREPrescription7 Feb 2019
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 25MG;40MG; 12.5MG;40MGtablet · oralPHARMAZONEPrescription17 Sep 2019
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralMACLEODS PHARMSPrescription1 Jun 2023
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralALKEM LABS LTDPrescription11 Jul 2024
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralHETERO LABS LTD VPrescription25 Jul 2025
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralHANGZHOU BINJIANGPrescription20 Aug 2025
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralMSNPrescription26 Sep 2025
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralSCIEGEN PHARMSPrescription31 Mar 2026
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralMICRO LABSPrescription13 Apr 2026
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralNATCO PHARMA USADiscontinued26 Oct 2016
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralTEVA PHARMS USADiscontinued24 Apr 2017
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralTORRENTDiscontinued3 May 2017
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MG; 12.5MG;40MG; 25MG;40MGtablet · oralZYDUS PHARMSDiscontinued24 Feb 2023

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ACH-OLMESARTAN HCTZ0246894820 MG; 12.5 MGTABLET · ORALACCORD HEALTHCARE INC
ACH-OLMESARTAN HCTZ0246895640 MG; 12.5 MGTABLET · ORALACCORD HEALTHCARE INC
ACH-OLMESARTAN HCTZ0246896440 MG; 25 MGTABLET · ORALACCORD HEALTHCARE INC
AURO-OLMESARTAN HCTZ0247648720 MG; 12.5 MGTABLET · ORALAURO PHARMA INC
AURO-OLMESARTAN HCTZ0247649512.5 MG; 40 MGTABLET · ORALAURO PHARMA INC
AURO-OLMESARTAN HCTZ0247650925 MG; 40 MGTABLET · ORALAURO PHARMA INC
GLN-OLMESARTAN HCTZ0247570712.5 MG; 20 MGTABLET · ORALGLENMARK PHARMACEUTICALS CANADA INC.
GLN-OLMESARTAN HCTZ0247571512.5 MG; 40 MGTABLET · ORALGLENMARK PHARMACEUTICALS CANADA INC.
GLN-OLMESARTAN HCTZ0247572325 MG; 40 MGTABLET · ORALGLENMARK PHARMACEUTICALS CANADA INC.
NRA-OLMESARTAN HCTZ0250827312.5 MG; 20 MGTABLET · ORALNORA PHARMA INC
NRA-OLMESARTAN HCTZ0250828112.5 MG; 40 MGTABLET · ORALNORA PHARMA INC
NRA-OLMESARTAN HCTZ0250830340 MG; 25 MGTABLET · ORALNORA PHARMA INC
OLMESARTAN/HCTZ0250960112.5 MG; 20 MGTABLET · ORALSANIS HEALTH INC
OLMESARTAN/HCTZ0250962840 MG; 25 MGTABLET · ORALSANIS HEALTH INC
OLMESARTAN/HCTZ0250963612.5 MG; 40 MGTABLET · ORALSANIS HEALTH INC
OLMETEC PLUS0231961612.5 MG; 20 MGTABLET · ORALORGANON CANADA INC.
OLMETEC PLUS0231962412.5 MG; 40 MGTABLET · ORALORGANON CANADA INC.
OLMETEC PLUS0231963240 MG; 25 MGTABLET · ORALORGANON CANADA INC.
TEVA-OLMESARTAN / HCTZ0244311212.5 MG; 20 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-OLMESARTAN / HCTZ0244312040 MG; 12.5 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-OLMESARTAN / HCTZ0244313940 MG; 25 MGTABLET · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACBENICAR HCT 40-12.5 MG TABLET$17.20133per EA1 Jul 2026
US NADACOLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB$0.16502per EA23 Sep 2026
US NADACOLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB$0.21959per EA23 Sep 2026
US NADACOLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB$0.20907per EA23 Sep 2026
NHS Drug TariffOlmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets£12.9528 tablet1 Oct 2026
NHS Drug TariffOlmesartan medoxomil 20mg / Hydrochlorothiazide 25mg tablets£12.9528 tablet1 Oct 2026
NHS Drug TariffOlmesartan medoxomil 40mg / Hydrochlorothiazide 12.5mg tablets£17.5028 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.